Homozygous Familial Hypercholesterolemia

Evolocumab or Normal Strategies to Reach LDL Objectives in Acute Myocardial Infarction Upbound to PCI

A Study of Evolocumab on Carotid Artery Atherosclerotic Plaque Morphology Prior to Carotid EndArterectomy

Study of Zodasiran in Adolescent Participants With Homozygous Familial Hypercholesterolemia

A Phase 3 Study of Zodasiran in Adolescent and Adult Subjects With Homozygous Familial Hypercholesterolemia (YOSEMITE)

Safety and Effectiveness of Evinacumab for the Treatment of Homozygous Familial Hypercholesterolemia

Evaluate the Efficacy and Safety of Evinacumab in Pediatric Patients With Homozygous Familial Hypercholesterolemia

Effect of Evolocumab on Coronary Atherosclerosis

Evaluate the Long-Term Safety and Efficacy of Evinacumab in Patients With Homozygous Familial Hypercholesterolemia

Efficacy and Safety of Evinacumab in Patients With Homozygous Familial Hypercholesterolemia

Fourier Open-label Extension Study in Subjects With Clinically Evident Cardiovascular Disease in Selected European Countries

Safety, Tolerability and Efficacy of Evolocumab (AMG 145) in Children With Inherited Elevated Low-density Lipoprotein Cholesterol (Familial Hypercholesterolemia)

Evolocumab Compared to LDL-C Apheresis in Patients Receiving LDL-C Apheresis Prior to Study Enrollment

Open-label Extension (OLE) Study to Assess Safety and Efficacy of Evolocumab

Open-label Extension Study of Evolocumab (AMG 145) in Adults With Hyperlipidemia and Mixed Dyslipidemia

Study to Assess In-home Use of Evolocumab (AMG 145) Using a Prefilled Syringe or a Prefilled Autoinjector/Pen

Trial Evaluating PCSK9 Antibody in Subjects With LDL Receptor Abnormalities

Study of ARO-ANG3 in Participants With Homozygous Familial Hypercholesterolemia (HOFH)

Impact of Evolocumab in Cardiac Transplant Patients With CAV

Study of AKCEA-ANGPTL3-LRX (ISIS 703802) in Patients With Homozygous Familial Hypercholesterolemia (HoFH)

Study to Evaluate the Effects of MBX-8025 in Patients With HoFH

Study of REGN1500 in Participants With Homozygous Familial Hypercholesterolemia (HoFH)

Open Label Study of Long Term Evaluation Against LDL-C Trial

Comparing the Extent to Which Two Evolocumab Drug Products Are Made Available in the Body After a Single Subcutaneous Dose

Studies to Gain Insight How the Drugs PCSK9-inhibitors and Statins Affect Cholesterol and Bile Acid Metabolism

Estimation Study to Assess the Effect of Severe Renal Impairment and End-stage Renal Disease Hemodialysis on the Pharmacokinetics of Evolocumab

Compassionate Use of Evinacumab

Evolocumab Pregnancy Exposure Registry

Long Term Post Marketing Specified Drug Use Result Survey for Evolocumab in Japan

LOWER: Lomitapide Observational Worldwide Evaluation Registry